We translate new scientific knowledge into benefits for health and value for society
Our research has the potential to improve people’s lives
Head of the “Cellular and Systems Neurobiology” Group
For CRG Community & Inventors
Research activities often lead to discoveries and inventions, and to the development of new tools and materials that may benefit society. TBDO helps CRG scientists realize the potential of their cutting-edge research, promoting the transition of their discoveries and ideas from the lab into real-life benefits.
CRG offers a variety of cutting-edge avenues for collaboration. TBDO is committed to working with industry partners and investors for the progression of CRG research into benefits for society. Our team facilitates this translation by fostering relationships that bridge the gap between early stage technologies and commercialization.
CRG is a globally recognized leader in knowledge creation. TBDO nurtures this fertile environment by providing its community with the knowledge, support and networking opportunities needed to develop an entrepreneurial mindset to make social impact.
06/10/201710:00RAMÓN Y CAJALTBDO SessionsLluís Armengol/Ruth Muñoz/Luis Ruiz/Leandro VetcherCSO and CEO of qGenomics/CSO of Leukos Biotech/CEO at Spherium Biomed/Director of Harvard’s Blavatnik Biomedical AcceleratorRound Table discussion in the context of the 4th CRG BioBusiness School.Host: Cironi López, PabloAbstract:These four seasoned and new entrepreneurs in the biotech sector will share their motivations to become entrepreneurs, and experiences in doing so.
02/10/201709:30CHARLES DARWINTBDO SessionsAndrés G. FernándezFerrer Advanced Biotherapeutics"Biopharma industry: Decision process on project selection and investment prioritization"Host: Cironi López, PabloAbstract:As Director of Ferrer Advanced Biotherapeutics, the Biotech Research Division of Ferrer International, Andrés G. Fernández and his team work to actively identify and select high added-value biopharmaceutical projects that they help to transform into real products in a variety of therapeutic and diagnostic areas. Previous to his current position, Andrés held a number of executive and scientific responsibilities at Ferrer, Almirall and
Salvat laboratories, where he helped to successfully develop and launch an important...